Skip to main content
spacbrain

Minovia Therapeutics

Terminated

Healthcare

What it is
A private company in healthcare preparing to list via a SPAC merger. Full profile in progress.
What it’s doing now
Merging with Launch One Acquisition Corp. (LPAA) — terminated, announced Jun 25, 2025.
What you should know
Data is still being assembled for this company — what is shown below is everything we have verified so far.
Profile in progress — we only publish what we can verify in filings, and for this company that work isn’t finished. Identity and deal facts above are current; business detail, financials and peers will appear as the filings are parsed.

What the company says about itself

Web research — not audited
What our web check found

[WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The merger is anticipated to conclude in Q4 2025." [https://redesign.longevity.technology/news/longevity-biotech-minovia-plans-180m-spac/] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "On January 30, 2026, Launch One Acquisition Corp. and Minovia Therapeutics Ltd. ended its Business Combination Agreement." [https://www.theglobeandmail.com/investing/markets/stocks/LPAA/pressreleases/40813/launch-one-acquisition-minovia-deal-terminated-new-target-sought/] [WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Minovia Therapeutics and Launch One Acquisition Corp. announced a definitive business combination agreement valued at $180 million pre-money" [https://trial.medpath.com/news/minovia-therapeutics-announces-180m-spac-merger-to-advance-first-in-class-mitochondrial-therapy-platform] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "On January 30, 2026, Launch One Acquisition Corp. and Minovia Therapeutics ... ended its Business Combination" [https://www.theglobeandmail.com/investing/markets/stocks/LPAA/pressreleases/40813/launch-one-acquisition-minovia-deal-terminated-new-target-sought/] [WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "Minovia Therapeutics and Launch One Acquisition Corp. announced a definitive business combination agreement valued at $180 million pre-money" [https://trial.medpath.com/news/minovia-therapeutics-announces-180m-spac-merger-to-advance-first-in-class-mitochondrial-therapy-platform] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "On January 30, 2026, Launch One Acquisition Corp. and Minovia Therapeutics ended its Business Combination Agreement" [https://www.theglobeandmail.com/investing/markets/stocks/LPAA/pressreleases/40813/launch-one-acquisition-minovia-deal-terminated-new-target-sought/]

Source: company web presence · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Minovia Therapeutics is merging with Launch One Acquisition Corp. (LPAA), a $230M SPAC currently marked Deal terminated and trading at $10.76 against $10.86 in trust per share.

Headline equity value$180M

Structure per SEC accession(s) 0001213900-25-060421; 0001213900-26-011726, 0001213900-25-060421. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Was this deal done at an expensive or a cheap valuation?

SpacBrain’s read on the price

No multiple can be computed

We hold no revenue figure in US dollars for Minovia Therapeutics Ltd., so there is nothing to divide the price by and no multiple can be struck. It is not recorded as pre-revenue either — this is a gap in our record, not a finding that the company has no sales. The deal values it at $180M regardless.

We have not extracted a revenue figure for this company from its filings yet. That is our gap, not a statement about the business.

What the buyers are paying for the whole company$180M

Announced equity value (net debt unknown).

Divided by what the company actually sells in a yearno revenue figure on file

Not extracted from the filings yet.

= what this deal pays for every dollar of those salesno multiple

Not computable — no revenue figure has been extracted from the filings yet.

What the stock market pays for its closest listed peersno comparable multiple

No listed comparable carries a revenue multiple we can use.

What qualifies the figures above

  • The target's cash and debt are not in the filings we have, so this is an equity value used as a stand-in for enterprise value.

Common questions

Is Minovia Therapeutics going public?

Minovia Therapeutics has a signed merger with the SPAC Launch One Acquisition Corp. (LPAA), announced Jun 25, 2025. Deal status: Terminated.

What is Minovia Therapeutics's SPAC deal valuation?

The announced headline equity value is $180M.

Was Minovia Therapeutics bought at an expensive or a cheap valuation?

We hold no revenue figure in US dollars for Minovia Therapeutics Ltd., so there is nothing to divide the price by and no multiple can be struck. It is not recorded as pre-revenue either — this is a gap in our record, not a finding that the company has no sales. The deal values it at $180M regardless.

Does Minovia Therapeutics have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.

Other healthcare deals
Same sponsor’s other SPACs
  • ARTC — Art Technology Acquisition · Searching
  • LPCV — Launchpad Cadenza Acquisition Corp I · Searching
  • CCII — Cohen Circle II · Searching
  • WENN — WEN Acquisition Corp · Searching
  • CCIR — Cohen Circle Acquisition Corp. I · Closed (deSPAC)
  • LPBB — Launch Two Acquisition Corp. · Deal announced